Pakistan Mandates 2D Barcodes on All Medicines to Combat Counterfeits

ISLAMABAD: The Pakistani government has announced that all medicines manufactured within the country must include a 2D barcode and serial number starting October 10, as part of a robust initiative to eliminate counterfeit drugs from the market. Imported medicines lacking this essential coding will also be barred from sale nationwide.

Health Minister Mustafa Kamal emphasized the importance of this new regulation during a recent meeting where he reviewed the trial of the barcode system. He stated that the move is aimed at enhancing drug safety and ensuring that consumers receive authentic medications. The initiative is part of a broader strategy to protect public health and combat the rising issue of counterfeit pharmaceuticals.

This regulation is expected to significantly impact the pharmaceutical industry and consumer safety in Pakistan. By enforcing strict labeling requirements, the government aims to build trust among citizens regarding the authenticity of medicines. The move also aligns with global efforts to tackle the counterfeit drug trade, which poses serious health risks.

Looking ahead, the Ministry of Health plans to conduct further assessments of the barcode system’s implementation and effectiveness. Stakeholders in the pharmaceutical sector are urged to comply with the new regulations to avoid disruptions in the supply chain and ensure public health is prioritized.